Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 9;8(7):102585.
doi: 10.1016/j.rpth.2024.102585. eCollection 2024 Oct.

How to treat patients with bleeding disorder of unknown cause?

Affiliations

How to treat patients with bleeding disorder of unknown cause?

Caroline Mussert et al. Res Pract Thromb Haemost. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Overview of current periprocedural hemostatic prophylaxis in BDUC and future perspectives. BDUC, bleeding disorder of unknown cause. This figure was created with biorender.com

References

    1. Baker R.I., Choi P., Curry N., Gebhart J., Gomez K., Henskens Y., et al. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024;22:2059–2070. - PubMed
    1. Gebhart J., Hofer S., Panzer S., Quehenberger P., Sunder-Plassmann R., Hoermann G., et al. High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB) Haemophilia. 2018;24:405–413. - PubMed
    1. MacDonald S., Wright A., Beuche F., Downes K., Besser M., Symington E., et al. Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment. Int J Lab Hematol. 2020;42:116–125. - PubMed
    1. Mehic D., Neubauer G., Janig F., Kaider A., Ay C., Pabinger I., et al. Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank. J Thromb Haemost. 2023;21:1757–1768. - PubMed
    1. Quiroga T., Goycoolea M., Panes O., Aranda E., Martinez C., Belmont S., et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. a prospective study of 280 patients and 299 controls. Haematologica. 2007;92:357–365. - PubMed

LinkOut - more resources